1. AB0656 Clinical Relevance of Measuring Free versus Total Anti-Infliximab Antibodies in Patients with Spondyloarthritis. (15th July 2016) Authors: Ruiz del Agua, A.; Pascual, J.; Torres, N.; Pascual-Salcedo, D.; Martínez, A.; Jurado, T.; Plasencia, C.; Balsa, A.; Ruiz-Argüello, B.; Maguregui, A.; Ametzazurra, A.; Martínez, A.; Nagore, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0212 Comparison Study of Tests Available To Monitor Tocilizumab Therapy in Rheumatic Patients. (15th July 2016) Authors: Martín, S.; Ruiz del Agua, A.; Torres, N.; Pascual-Salcedo, D.; Plasencia, C.; Jurado, T.; Martínez, A.; Balsa, A.; Ruiz-Argüello, B.; Martínez, A.; Navarro, R.; Nagore, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0015 Antibodies To Infliximab in Remicade-Treated Rheumatic Patients Show Identical Reactivity towards Biosimilar CT-P13. (15th July 2016) Authors: Ruiz-Argüello, B.; Maguregui, A.; Ruiz del Agua, A.; Pascual-Salcedo, D.; Martínez, A.; Jurado, T.; Plasencia, C.; Balsa, A.; Rosas, J.; Llinares-Tello, F.; Torres, N.; Martínez, A.; Nagore, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗